Showing results (11-20 of 45) with videos related to
Sort By:
Pageof 5
Digestive Diseases and Sciences|February 11, 2023
Ulcerative Colitis-Symptom Questionnaire: Valid for Use in Adults with Moderately to Severely Active Ulcerative ColitisJulian Panes, Anthony Otley, Yuri Sanchez Gonzalez, et al.Journal of Crohn'S & Colitis|June 9, 2021
Upadacitinib Treatment Improves Symptoms of Bowel Urgency and Abdominal Pain, and Correlates With Quality of Life Improvements in Patients With Moderate to Severe Ulcerative ColitisSubrata Ghosh, Yuri Sanchez Gonzalez, Wen Zhou, et al.Gut|February 15, 2011
The mucosal addressin cell adhesion molecule antibody PF-00547,659 in ulcerative colitis: a randomised studySéverine Vermeire, Subrata Ghosh, Julian Panes, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2006
TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's diseaseSilvio Danese, Miquel Sans, Franco Scaldaferri, et al.Journal of Crohn'S & Colitis|September 21, 2021
Association Between Proposed Definitions of Clinical Remission/Response and Well-Being in Patients With Crohn's DiseaseWilliam J Sandborn, James D Lewis, Julian Panes, et al.The Journal of Clinical Investigation|June 9, 2007
Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel diseaseFranco Scaldaferri, Miquel Sans, Stefania Vetrano, et al.Alimentary Pharmacology & Therapeutics|October 21, 2022
Effect of risankizumab on health-related quality of life in patients with Crohn's disease: results from phase 3 MOTIVATE, ADVANCE and FORTIFY clinical trialsLaurent Peyrin-Biroulet, Subrata Ghosh, Scott D Lee, et al.Journal of Crohn'S & Colitis|December 28, 2016
Five-year Safety Data From ENCORE, a European Observational Safety Registry for Adults With Crohn's Disease Treated With Infliximab [Remicade®] or Conventional TherapyGeert D'Haens, Walter Reinisch, Jean-Frederic Colombel, et al.Gastroenterology|November 18, 2008
VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesisFranco Scaldaferri, Stefania Vetrano, Miquel Sans, et al.Gastroenterology|February 25, 2020
Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative ColitisWilliam J Sandborn, Subrata Ghosh, Julian Panes, et al.Pageof 5